MedSchool: Ace Your OSCEsThe Medical Company
GET - On the App Store
Drug Guide


    Subcut / IV
  • Mechanism of Action

  • A human monoclonal antibody directed against p40, a shared subunit present in both IL-12 and IL-23. Inhibition of IL-12 results in reduced differentiation of TH1 cells, while inhibition of IL-23 results in reduced induction of TH17 cells.

Clinical Use

  • Indications
  • Severe refractory Crohn's disease
  • Refractory psoriatic arthritis
  • Moderate to severe plaque psoriasis
  • Adverse Effects
  • Injection site reactions
  • Upper respiratory tract infection
  • Dizziness
  • Headache
  • Nausea / vomiting / diarrhoea
  • Myalgias / arthralgias
  • Fatigue
Want more info like this?
  • Your electronic clinical medicine handbook
  • Guides to help pass your exams
  • Tools every medical student needs
  • Quick diagrams to have the answers, fast
  • Quizzes to test your knowledge
Sign Up Now

Snapshot: Initialising...